Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases.

Authors:
Bhatti GK; Gupta A; Pahwa P; Khullar N; Singh S and 6 more

Journal:
Biomed J

Publication Year: 2022

DOI:
10.1016/j.bj.2022.05.002

PMCID:
PMC9661512

PMID:
35568318

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Biomed J

Abbreviation: Biomed J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Antibody induction in mice by liposome-displayed recombinant enterotoxigenic Escherichia coli (ETEC…
Zhou S; Yu KOA; Mabrouk MT and 10 more (2023) - Transparency Score: 3/6
Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions…
Moura PC; Raposo M; Vassilenko V. (2023) - Transparency Score: 3/6
Cellular senescence and the host immune system in aging and age-related disorders.
Giannoula Y; Kroemer G; Pietrocola F. (2023) - Transparency Score: 3/6
Clinical validation of a saliva-based matrix metalloproteinase-1 rapid strip test for detection of …
Chu LJ; Chang YT; Chien CY and 10 more (2023) - Transparency Score: 3/6
Exercise, mitochondrial dysfunction and inflammasomes in skeletal muscle.
Slavin MB; Khemraj P; Hood DA. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest The authors have no financial or ethical conflicts of interest to report."

Evidence found in paper:

"This research has been supported by 10.13039/501100001843Science and Engineering Research Board, a statutory body of the 10.13039/501100006143Department of Science and Technology, Government of India (No. TAR/2020/000430 and EEQ/2020/000188). The authors also would like to thank 10.13039/100000002National Institutes of Health, USA, for funding various projects - R01AG042178, R01AG47812, R01NS105473, AG060767, AG069333, and AG066347 to (PHR). BioRender software was used to create the figures appended in this manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025